Masco Reports Q4 & FY25 Results, Authorizes $2B Buyback, Guides for 2026 EPS Growth
MAS sits 25% above its 52-week low of $56.55 on elevated volume (1.9× avg).
Summary
Masco reported a decline in 2025 financial results but issued positive 2026 EPS guidance and authorized a substantial $2.0 billion share repurchase program.
Key Events · Earnings and Guidance · MAS
-
Q4 & FY25 Financial Performance
Net sales decreased 2% in Q4 and 3% for the full year 2025. Adjusted earnings per share decreased 8% to $0.82 in Q4 and 3% to $3.96 for the full year 2025.
-
2026 Outlook Provided
The company anticipates full-year 2026 adjusted earnings per share in the range of $4.10 to $4.30, indicating growth from 2025. Sales are expected to be roughly flat to up low-single digits.
-
New $2.0 Billion Share Repurchase Program
The Board of Directors authorized a new $2.0 billion share repurchase program, effective immediately and replacing the existing authorization, signaling strong capital allocation.
-
Restructuring Actions Initiated
Masco incurred $18 million in restructuring charges in Q4 2025 and expects an additional $50 million in 2026, aimed at streamlining the business, reducing headcount, and optimizing operations for future margin expansion.
Analysis · MAS · Manufacturing
Masco Corporation reported a decline in net sales and adjusted EPS for both Q4 and full-year 2025, reflecting a challenging macroeconomic environment. However, the company provided an optimistic outlook for 2026, projecting adjusted earnings per share growth. A significant highlight is the authorization of a new $2.0 billion share repurchase program, underscoring management's confidence and commitment to shareholder returns. The company also announced restructuring actions and a segment realignment aimed at streamlining operations and driving future margin expansion.
At the time of this filing, MAS was trading at $70.73 on NYSE in the Manufacturing sector, with a market capitalization of approximately $14.9B. The 52-week trading range was $56.55 to $79.16. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.